Abstract
BackgroundPreviously an association has been demonstrated between drug levels and clinical activity in Spondyloarthritis (SpA) patients treated with Infliximab, Adalimumab or Etanercept. Until now, there is not enough evidence about...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have